Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasisulam in Soft Tissue Sarcoma
NCT00490451Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2007
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of tasisulam in soft tissue sarcoma (STS), sponsored by Eli Lilly and Company. Started Aug 2007; status: completed.
02
Drugs
tasisulam
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00490451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490451.